ABCR  Vol.5 No.3 , July 2016
Sensitivity and Specificity of Pre-Operative Staging of the Axilla When Using OSNA in Breast Cancer Patients
Abstract: Introduction: All patients with a new diagnosis of breast cancer undergo pre-operative axillary ultrasound (US) and biopsy to identify axillary metastases. The efficacy of this approach at identifying metastatic disease is particularly important if an intra-operative technique of assessment is used. This paper is the first to report the sensitivity and specificity of pre-operative axillary ultrasound within the context of the routine use of OSNA (one step nucleic acid amplification) (Sysmex, Japan), a molecular assay technique for the intra-operative analysis of axillary lymph nodes. This knowledge will help counsel patients prior to the procedure and inform economic analysis of the implications of this approach. Method: Consecutive patients diagnosed with invasive breast cancer between July 2009 and February 2012 at a single centre were identified by interrogation of MDT (multi disciplinary team) and surgical databases and a prospective database of all patients undergoing OSNA analysis. A standardised data collection sheet was used to record tumour characteristics and the nodal stage for each patient. These results were used to document the efficacy of preoperative US and biopsy of the axilla in comparison to intraoperative OSNA analysis. The data were then compared between two groups of patients, those whose nodes had been assessed using OSNA (the OSNA group) and those nodes had been tested using standard histopathological examination (the non-OSNA group). Results: A total of 377 eligible patients were identified. Within the OSNA group (n = 240) the sensitivity of pre-operative axillary US was 29% which rose to 41% when micro-metastases were excluded. A specificity and positive predictive value of 100% was recorded. The negative predictive value was 74%. There were no significant differences to the efficacy when the nodes were assessed with standard histopathology. The detection rate of micro-metastases was significantly higher in the OSNA group (P = 0.001), but there was no statistically significant difference in those with macro-metastases (P = 0.457). Conclusions: There are no significant differences in the sensitivity and specificity achieved by pre-operative axillary US when compared to either post operative histopathology or OSNA molecular analysis as the gold standard. OSNA, however, does increase the detection of micro-metastases.
Cite this paper: Horsnell, J. , Choudhry, K. , Urriza-Rodriguez, D. , Valencia, A. and Rayter, Z. (2016) Sensitivity and Specificity of Pre-Operative Staging of the Axilla When Using OSNA in Breast Cancer Patients. Advances in Breast Cancer Research, 5, 103-110. doi: 10.4236/abcr.2016.53012.

[1]   Alvarez, S., Anorbe, E., Alcorta, P., Lopez, F., Alonso, I. and Cortes, J. (2006) Role of Sonography in the Diagnosis of Axillary Lymph Node Metastases in Breast Cancer: A Systematic Review. American Journal of Roentgenology, 186, 1342-1348.

[2]   National Institute for Health and Clinical Excellence (2009) Early and Locally Advanced Breast Cancer. Clinical Guideline 80, National Institute for Health and Clinical Excellence, London WC1V 6NA.

[3]   Tew, K., Irwig, L., Matthews, A., Crowe, P. and Macaskill, P. (2005) Meta-Analysis of Sentinel Node Imprint Cytology in Breast Cancer. British Journal of Surgery, 92, 1068-1080.

[4]   Creager, A.J. and Geisinger, K.R. (2002) Intraoperative Evaluation of Sentinel Lymph Nodes for Breast Carcinoma: Current Methodologies. Advances in Anatomic Pathology, 9, 233-243.

[5]   Snook, K.L., Layer, G.T., Jackson, P.A., de Vries, C.S., Shousha, S., Sinnett, H.D., Nigar, E., Singhal, H., Chia, Y., Cunnick, G. and Kissin, M.W. (2001) Multicentre Evaluation of Intraoperative Molecular Analysis of Sentinel Lymph Nodes in Breast Carcinoma. British Journal of Surgery, 98, 527-535.

[6]   Layfield, D.M., Agrawal, A., Roche, H. and Cutress, R.I. (2011) Intraoperative Assessment of Sentinel Lymph Nodes in Breast Cancer. British Journal of Surgery, 98, 4-17.

[7]   Tan, L.K., Giri, D., Hummer, A.J., Panageas, K.S., Brogi, E., Norton, L., Hudis, C., Borgen, P.I. and Cody, H.S. (2008) Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients with 20-Year Follow-Up. Journal of Clinical Oncology, 26, 1803-1809.

[8]   Leenders, M., Broeders, M., Croese, C., Richir, M., Go, H., Meijer, S., Langenhorst, B. and Schreurs, W. (2012) Ultrasound and Fine Needle Aspiration Cytology of Axillary Lymph Nodes in Breast Cancer. To do or Not to Do? Breast, 21, 578-583.

[9]   Cools-Lartigue, J., Sinclair, A., Trabulsi, N., Meguerditchian, A., Nesurolle, B., Fuhrer, R. and Meterissian, S. (2013) Preoperative Axillary Ultrasound and Fine-Needle Aspiration Biopsy in the Diagnosis of Axillary Metastases in Patients with Breast Cancer: Predictors of Accuracy and Future Implications. Annals of Surgical Oncology, 20, 819-827.

[10]   Castellano, I., Macrì, L., Deambrogio, C., Balmativola, D., Bussone, R., Ala, A., Coluccia, C. and Sapino, A. (2012) Reliability of Whole Sentinel Lymph Node Analysis by One-Step Nucleic Acid Amplification for Intraoperative Diagnosis of Breast Cancer Metastases. Annals of Surgery, 255, 334-342.

[11]   Visser, M., Mehdi J., Horstman, A., Brink, A., Pol, R., van Diest, P., Snijders, P. and Meijer, C. (2008) Intra-Operative Rapid Diagnostic Method Based on CK19 mRNA Expression Node Metastases for the Detection of Lymph Node Metastases in Breast Cancer. International Journal of Cancer, 122, 2562-2567.

[12]   Chaudhry, A., Williams, S., Cook, J., Jenkins, M., Sohail, M., Calder, M., Winters, Z. and Rayter, Z. (2014) The Real-Time Intra-Operative Evaluation of Sentinel Lymph Nodes in Breast Cancer Patients Using One Step Nucleic Acid Amplification (OSNA) and Implications for Clinical Decision-Making. European Journal of Surgical Oncology, 40, 150-157.

[13]   (2013) DG8 Intra-Operative Tests (RD-100i OSNA System and Metasin Test) for Detection of Sentinel Lymph Node Metastases in Breast Cancer: Guidance. NICE Aug 2013, 7.

[14]   Galimberti, V., Cole, B.F., Zurrida, S., et al. (2013) Axillary Dissection versus No Axillary Dissection in Patients with Sentinel-Node Micrometastases (IBCSG 23-01): A Phase 3 Randomised Controlled Trial. The Lancet Oncology, 14, 297-305.

[15]   Goldhirsch1, A., Winer, E., Coates, A.S., Gelber, R.D., Piccart-Gebhart, M., Thürlimann, B. and Senn, H. (2013) Personalizing the Treatment of Women with Early Breast Cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Annals of Oncology, 24, 2206-2223.